Physician profile
Arooj Khan
NPI 1811421738
$36,734.95
in general payments reported to CMS, 2019-2025
12 companies · $6,741 in 2025
The $6,741 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $600 · 2023: $8,027 · 2024: $21K · 2025: $6,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $28K · Travel and Lodging: $3,872 · Food and Beverage: $3,605 · Education: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $27,500.00 |
| Travel and Lodging | $3,871.50 |
| Food and Beverage | $3,605.49 |
| Education | $897.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27,077.94 | 2021-2025 | Ensite, Gallant, Ensite Precision |
| Boston Scientific Corporation | $6,013.84 | 2022-2025 | General - Therapies, Resonate El Icd Vr, Watchman Flx |
| Medtronic, INC. | $3,015.13 | 2023-2025 | Micra, Linq II, Affera Mapping System |
| Sanofi-Aventis U.S. LLC | $246.65 | 2021-2022 | |
| Getinge USA Sales, LLC | $103.84 | 2023-2025 | Cardiohelp, Cardiosave Rescue |
| Philips North America LLC | $58.85 | 2024 | (Ao0) Igt Devices Intracardiac |
| Biosense Webster, INC. | $54.64 | 2025 | Carto 3 |
| Abiomed | $45.66 | 2021-2025 | |
| Biotronik INC. | $43.00 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.55 | 2025 | Lifevest |
| Volta Medical INC | $20.70 | 2024 | Vx1 |
| Lilly USA, LLC | $17.15 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arooj Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.